Acadia Pharma (ACAD) Tops Q1 EPS by 5c, Misses on Revenue; Offers FY24 Guidance
Go back to Acadia Pharma (ACAD) Tops Q1 EPS by 5c, Misses on Revenue; Offers FY24 Guidance| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 22.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.60 | 52 Week High | $42.49 | |||
| Open | $22.60 | 52 Week Low | $16.64 | |||
| Day High | $22.60 | P/E | N/A | |||
| Day Low | $22.60 | EPS | $-0.42 | |||
| Volume | 253 | |||||
